Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4273306 | The Journal of Sexual Medicine | 2006 | 15 Pages |
Abstract
The investigation of FSD is an evolving area in that new definitions and a new model for female sexual functioning have been recently proposed. There is a need for experts in the field and regulating authorities to reach a consensus regarding appropriate inclusion and exclusion criteria for FSD trials and main outcome measures appropriate for the evaluation of drug interventions. This consensus should also determine which treatment effect is considered to be clinically relevant. Treatment efficacy and clinical relevance should be related to outcomes which are meaningful for affected women. Nijland E, Davis S, Laan E, and Schultz WW. Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction. J Sex Med 2006;3:763-777.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Esmé MD, Susan MD, PhD, Ellen PhD, Willibrord Weijmar MD, PhD,